AVE 16.7% 0.3¢ avecho biotechnology limited

mass market personal care

  1. 10,009 Posts.
    In Nov/Dec, we saw an investor presemtation to SI's in Asia and Newsletter, talking up the probability of TPM being used Mass Market Products.

    As this has been bfewing for some time, first mentioned in May 2010 at the AGM presentation and more formally announced in Sept 2011,

    http://www.phosphagenics.com/site/DefaultSite/filesystem/documents/2011%2009%2014%20Phosphagenics%20Signs%20Development%20Deal%20with%20Global%20Cosmetic%20Company.pdf

    The newsletter even went into details about manufacturing facilities near the customers factory.

    As usual, we were all expecting news soon, it is less than 4 months since formal announcement. This makes me wonder if the initial trials of TPM pwered product are so good the size and scope of the deal are being expanded.

    The clue might be talk of factories, global companies must be certain of their supply chain. The lead times for mrketing,packaging,sales, to be geared is likely lengthy.

    If TPM has surprised the customer to the positive, preparing for a bigger product rollout and major shift in Company Marketing to hinge on TPM would increase the time taken for a signed off committmant.

    Whilst some are getting jaded by the wait, my view is, this R & D agreement might just be everything we have been hoping for. Could it beat OXYPATCH to the punch asa company maker.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $110 43.27K

Buyers (Bids)

No. Vol. Price($)
53 94238418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 75854078 21
View Market Depth
Last trade - 15.33pm 04/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.